Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors: a hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1).

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biochemical Pharmacology

• Publication date

  1998-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0006-2952(98)00053-7PMID 9714299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The HIV-1 Rev protein.

  1998cited by this paper
• Is hypusine essential for eukaryotic cell proliferation?

  1997cited by this paper
• Dual role of HIV Tat in regulation of apoptosis in T cells.

  1997cited by this paper
• Ultrastructural and confocal laser scanning microscopic examination of TUNEL‐positive cells

  1997cited by this paper
• The dual effect of mimosine on DNA replication.

  1997cited by this paper
• Nucleocytoplasmic Transport

  1996cited by this paper
• Intracellular Expression of Cellular eIF-5A Mutants Inhibits HIV-1 Replication in Human T Cells: A Feasibility Study

  1996cited by this paper
• Inhibition of HIV-1 Replication in Lymphocytes by Mutants of the Rev Cofactor eIF-5A

  1996cited by this paper
• Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity

  1995cited by this paper
• Rev‐dependency of expression of human immunodeficiency virus type 1 gag and env genes

  1995cited by this paper
• Mimosine Arrests DNA Synthesis at Replication Forks by Inhibiting Deoxyribonucleotide Metabolism (*)

  1995cited by this paper
• Cyclosporine-induced apoptosis in CD4+ T lymphocytes and computer-simulated analysis: modeling a treatment scenario for HIV infection.

  1995cited by this paper
• Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes

  1995cited by this paper
• Specific inhibition of eIF-5A and collagen hydroxylation by a single agent. Antiproliferative and fibrosuppressive effects on smooth muscle cells from human coronary arteries.

  1995cited by this paper
• Therapeutic Use of Chelating Agents in Iron Overload

  1995cited by this paper
• The polypeptide chain of eukaryotic initiation factor 5A occurs in two distinct conformations in the absence of the hypusine modification.

  1995cited by this paper
• Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort

  1995cited by this paper
• Iron chelators induce apoptosis in proliferating cells

  1995cited by this paper
• Apoptosis of HIV-infected cells following treatment with Sho-Saiko-to and its components.

  1995cited by this paper
• Results of long‐term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators

  1995cited by this paper
• Detection of a sub‐set of polysomal mRNAs associated with modulation of hypusine formation at the G1‐S boundary Proposal of a role for eIF‐5A in onset of DNA replication

  1995cited by this paper
• Mimosine inhibits viral DNA synthesis through ribonucleotide reductase.

  1994cited by this paper
• Bone marrow declines as a site of B-cell precursor differentiation with age: relationship to thymus involution.

  1994cited by this paper
• Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae.

  1994cited by this paper
• 1H NMR studies of the high-affinity Rev binding site of the Rev responsive element of HIV-1 mRNA: base pairing in the core binding element.

  1994cited by this paper
• A molecular rheostat: Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression

  1994cited by this paper
• The function of the hypusine-containing proteins of yeast and other eukaryotes is well conserved

  1994cited by this paper
• Inhibition of human immunodeficiency virus type-1 env expression by C-5 propyne oligonucleotides specific for Rev-response element stem-loop V.

  1994cited by this paper
• Constitutive production of nonenveloped human immunodeficiency virus type 1 particles by a mammalian cell line and effects of a protease inhibitor on particle maturation

  1994cited by this paper
• Evidence that HIV‐1 Rev directly promotes the nuclear export of unspliced RNA.

  1994cited by this paper
• Induced gene expression of the hypusine-containing protein eukaryotic initiation factor 5A in activated human T lymphocytes.

  1994cited by this paper
• A functional interaction between Rev and yeast pre‐mRNA is related to splicing complex formation.

  1994cited by this paper
• Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation.

  1994cited by this paper
• The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm.

  1994cited by this paper
• Programmed cell death: a fundamental protective response to pathogens.

  1994cited by this paper
• Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication.

  1994cited by this paper
• Inhibition of HIV infection by baicalin--a flavonoid compound purified from Chinese herbal medicine.

  1993cited by this paper
• Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans- activation

  1993cited by this paper
• Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication.

  1993cited by this paper
• Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes

  1993cited by this paper
• Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation.

  1993cited by this paper
• Hypusine is essential for eukaryotic cell proliferation.

  1993cited by this paper
• Medication costs associated with the care of HIV-infected patients.

  1993cited by this paper
• Induction of HIV-1 replication in a chronically infected T-cell line by cytotoxic T lymphocytes.

  1993cited by this paper
• The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs

  1992cited by this paper
• Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells.

  1992cited by this paper
• Inhibition of human immunodeficiency virus type 1 Rev-Rev-response element complex formation by complementary oligonucleotides

  1992cited by this paper
• The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines.

  1992cited by this paper
• Care for AIDS patients in developing countries: a review.

  1992cited by this paper
• The HIV-1 Rev protein: prototype of a novel class of eukaryotic post-transcriptional regulators.

  1991cited by this paper
• Prolyl 4-hydroxylase, a target enzyme for drug development. Design of suppressive agents and the in vitro effects of inhibitors and proinhibitors.

  1991cited by this paper
• Translation initiation factor 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae

  1991cited by this paper
• The active site of deoxyhypusyl hydroxylase: use of catecholpeptides and their component chelator and peptide moieties as molecular probes.

  1991cited by this paper
• Mimosine reversibly arrests cell cycle progression at the G1-S phase border.

  1991cited by this paper
• Human tumor necrosis factor alpha gene regulation in phorbol ester stimulated T and B cell lines

  1991cited by this paper
• AIDS Drugs & the Pharmaceutical Industry: A Need For Reform

  1991cited by this paper
• Induction of human immunodeficiency virus type 1 expression in chronically infected cells is associated primarily with a shift in RNA splicing patterns

  1991cited by this paper
• Inhibition of HIV replication by baicalin and S. baicalensis extracts in H9 cell culture.

  1991cited by this paper
• A new class of reversible cell cycle inhibitors.

  1991cited by this paper
• Regulation of HIV‐1 gene expression

  1991cited by this paper
• Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs.

  1991cited by this paper
• AIDS drugs & the pharmaceutical industry: a need for reform.

  1991cited by this paper
• The HIV-1 Rev protein: a model system for coupled RNA transport and translation.

  1991cited by this paper
• A new compound which reversibly arrests T lymphocyte cell cycle near the G1/S boundary.

  1990cited by this paper
• Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.

  1990cited by this paper
• Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression.

  1990cited by this paper
• Pharmacokinetic studies in humans with the oral iron chelator 1,2‐dimethyl‐3‐hydroxypyrid‐4‐one

  1990cited by this paper
• A reversible arrest point in the late G1 phase of the mammalian cell cycle.

  1990cited by this paper
• Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

  1989cited by this paper
• Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone.

  1989cited by this paper
• rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.

  1989cited by this paper
• The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA

  1989cited by this paper
• Origin of the HIV-Susceptible Human CD4+ Cell Line H9

  1989cited by this paper
• Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells.

  1989cited by this paper
• Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function.

  1989cited by this paper
• Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.

  1988cited by this paper
• Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase.

  1986cited by this paper
• Quantitative assays for evaluation of HTLV-III inactivation procedures: tri(N-butyl)phosphate:sodium cholate and beta-propiolactone.

  1985cited by this paper
• Differences between collagen hydroxylases and 2-oxoglutarate dehydrogenase in their inhibition by structural analogues of 2-oxoglutarate.

  1985cited by this paper
• Evidence for extensive methylation of ribosomal RNA genes in a rat XC cell line.

  1983cited by this paper
• The biosynthesis of protein-bound hypusine (N epsilon -(4-amino-2-hydroxybutyl)lysine). Lysine as the amino acid precursor and the intermediate role of deoxyhypusine (N epsilon -(4-aminobutyl)lysine).

  1982cited by this paper
• A stereochemical concept for the catalytic mechanism of prolylhydroxylase: applicability to classification and design of inhibitors.

  1982cited by this paper
• Programmed cell death.

  1974cited by this paper

• The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases

  2023cites this paper
• New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer

  2022cites this paper
• Transcriptional and Translational Dynamics of Zika and Dengue Virus Infection

  2022cites this paper
• eIF5A is activated by virus infection or dsRNA and facilitates virus replication through modulation of interferon production

  2022influential citation
• Biophysical and modeling-based approach for the identification of inhibitors against DOHH from Leishmania donovani.

  2022cites this paper
• Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology

  2022cites this paper
• PEDV infection affects the expression of polyamine-related genes inhibiting viral proliferation

  2022cites this paper
• Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities.

  2020cites this paper
• Synthesis and Mass Spectrometry Analysis of Mimosine-Containing Peptides

  2020cites this paper
• Eukaryotic initiation factor 5A and Ca2+/calmodulin‐dependent protein kinase 1D modulate trophoblast cell function

  2018cites this paper
• Hypusination of eIF5A as a Target for Antiviral Therapy

  2017cites this paper
• Polyamines and Their Role in Virus Infection

  2017cites this paper
• Regulation of gene expression by translation factor eIF5A: Hypusine-modified eIF5A enhances nonsense-mediated mRNA decay in human cells

  2017cites this paper
• Targeting deoxyhypusine hydroxylase activity impairs cap-independent translation initiation driven by the 5'untranslated region of the HIV-1, HTLV-1, and MMTV mRNAs.

  2016cites this paper
• Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication

  2016cites this paper
• Repositioning the Old Fungicide Ciclopirox for New Medical Uses.

  2016cites this paper
• Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial

  2016cites this paper
• New insights into novel inhibitors against deoxyhypusine hydroxylase from plasmodium falciparum: compounds with an iron chelating potential

  2015cites this paper
• Structural and functional investigation into acetyl-coenzyme A synthase and methyltransferase from human pathogen Clostridium difficile.

  2013cites this paper
• MULTIPLE NUCLEAR RECEPTORS AND CIRCADIAN RHYTHM FACTORS MODULATE HUMAN CYTOMEGALOVIRUS REPLICATION

  2013cites this paper
• Drug-Induced Reactivation of Apoptosis Abrogates HIV-1 Infection

  2013cites this paper
• A Unique Modification of the Eukaryotic Initiation Factor 5A Shows the Presence of the Complete Hypusine Pathway in Leishmania donovani

  2012cites this paper
• Hydroxypyridinones as “privileged” chelating structures for the design of medicinal drugs

  2012cites this paper
• Advances in iron chelation: an update

  2011cites this paper
• Preventing Fusarium head blight of wheat and cob rot of maize by inhibition of fungal deoxyhypusine synthase.

  2011cites this paper
• Cloning, expression and functional characterization of deoxyhypusine synthase from the pathogenic fungus Fusarium graminearum Schwabe (teleomorph Gibberella zeae), wheat (Triticum aestivum L.) and maize (Zea mays L.)

  2011cites this paper
• Solid-phase synthesis of mimosine tetrapeptides and their inhibitory activities on neuraminidase and tyrosinase.

  2011cites this paper
• Down-regulation of hypusine biosynthesis in plasmodium by inhibition of S-adenosyl-methionine-decarboxylase

  2010cites this paper
• Revisiting an old acquaintance: role for eIF5A in diabetes.

  2010cites this paper
• Assessment of deoxyhypusine hydroxylase as a putative, novel drug target

  2010cites this paper
• Cloning and Expression Profile of Deoxyhypusine Snyhtase Gene and Deoxyhypusine Hydroxylase Gene in Silkworm, Bombyx mori

  2009cites this paper
• Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A

  2009cites this paper
• Human deoxyhypusine hydroxylase, an enzyme involved in regulating cell growth, activates O2 with a nonheme diiron center

  2009cites this paper
• In search of novel agents for therapy of tropical diseases and human immunodeficiency virus.

  2008cites this paper
• Inhibition of Apoptosis in Cryptosporidium parvum-Infected Intestinal Epithelial Cells Is Dependent on Survivin

  2008cites this paper
• Molecular cloning and functional expression of bovine deoxyhypusine hydroxylase cDNA and homologs.

  2007cites this paper
• Specificity of the Deoxyhypusine Hydroxylase-Eukaryotic Translation Initiation Factor (eIF5A) Interaction

  2007cites this paper
• Is there a role for eIF5A in translation?

  2007cites this paper
• Characterization of the pro-apoptotic function of eIF5A in human cancer cell lines

  2007cites this paper
• In search for novel agents in therapy of Plasmodium falciparum

  2007cites this paper
• Inhibition of multidrug-resistant HIV-1 by interference with cellular S-adenosylmethionine decarboxylase activity.

  2006cites this paper
• Piperidones with activity against Plasmodium falciparum

  2006influential citation
• Deoxyhypusine hydroxylase is a Fe(II)-dependent, HEAT-repeat enzyme. Identification of amino acid residues critical for Fe(II) binding and catalysis [corrected].

  2006cites this paper
• HIV-1 Rev function as target for antiretroviral drug development

  2006cites this paper
• Inhibition of hypusine biosynthesis in plasmodium: a possible, new strategy in prevention and therapy of malaria.

  2006cites this paper
• The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).

  2006cites this paper
• Role of protein modifications mediated by transglutaminase 2 in human viral diseases.

  2006cites this paper
• Modulation of Differentiation-related Gene 1 Expression by Cell Cycle Blocker Mimosine, Revealed by Proteomic Analysis*

  2005influential citation
• Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy.

  2005cites this paper
• Higher activity of recombinant bovine deoxyhypusine synthase vs. human deoxyhypusine synthase.

  2004cites this paper
• Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth

  2004cites this paper
• EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression.

  2003influential citation
• The HAG mechanism: a molecular rationale for the therapeutic application of iron chelators in human diseases involving the 2-oxoacid utilizing dioxygenases.

  2003cites this paper
• Spermidine metabolism in parasitic protozoa--a comparison to the situation in prokaryotes, viruses, plants and fungi.

  2003cites this paper
• EIF 3 p 170 , a Mediator of Mimosine Effect on Protein Synthesis and Cell Cycle Progression

  2003influential citation
• The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitro

  2002cites this paper
• TH EANTIFUNGA LDRU GCICLOPIRO XINHIBIT SDEOXYHYPUSIN EAND PROLIN EHYDROXYLATION ,ENDOTHELIA LCEL LGROWT HAND ANGIOGENESI SI NVITRO

  2002cites this paper
• Effects of 1,8-diaminooctane on the FIV Rev regulatory system.

  2002cites this paper
• Cyclin-dependent kinases as cellular targets for antiviral drugs.

  2002cites this paper
• Nuclear export mediated by the Rev/Rex class of retroviral Trans-activator proteins.

  2001cites this paper
• Modellsynthesen und Strukturaufklärung von Polyketiden sowie Arbeiten zur Biosynthese von Mimosin

  2001cites this paper
• Rev protein and its cellular partners.

  2000cites this paper
• Mimosine induces apoptosis in the HL60 human tumor cell line

  1999cites this paper